Spontaneous Adverse Drug Reaction Monitoring in a Tertiary Care Centre

Author:

Kaur Kirandeep1,Kanwal Preet1,Goyal Pardeep1,Singh Paramjit1,Yakhmi Sahil1,Jain Samriti1,Kaushal Sandeep1

Affiliation:

1. Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, India

Abstract

Background and Objective: Adverse drug reactions (ADRs) are associated with increased economic burden on the society. Monitoring of ADRs can help in decreasing the incidence of preventable adverse reactions. Methods: Under Pharmacovigilance Program of India, collection and reporting of ADRs has been going on at Dayanand Medical College and Hospital since January 2011. Here, we have analyzed the individual case safety reports (ICSRs) reported and uploaded between January 2017 and June 2019 from our centre. The ADR form provided by PvPI was used for collecting information, and the causality assessment was done according to the WHO-UMC scale. Results: A total of 498 ICSRs were uploaded through Vigiflow software during this period. Highest number of ADRs were recorded in the age group of 31-45 years (29.01%) and the least number of ADRs were recorded in the children less than 15 years of age (6.76%). General Medicine ward reported the highest number of ADRs and the antibiotics were most commonly associated with ADRs (26.21%), followed by antipsychotics (13.83%) and NSAIDs (12.14%). More than 90% of ADRs were non-serious (93.17%) and most of the ADRs were skin and soft tissue related (49.20%). Conclusion: Spontaneous reporting among indoor patients shows highest number of ADRs with use of antibiotics and almost all of the ADRs were non-serious in nature. Almost half of the total ADRs were skin and subcutaneous tissue related. Continuous efforts are required for further strengthening of the pharmacovigilance program of India.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference26 articles.

1. WHO. WHO | Pharmacovigilance In: WHO. World Health Organization 2015. Available from: [cited 16 Oct 2019]. Available:

2. Desai C.K.; Iyer G.; Panchal J.; Shah S.; Dikshit R.K.; An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res 2011,2(4),129-136

3. UMC The story of UMC and the WHO Programme ; [cited 16 Oct 2019] Available: 2019

4. WHO. WHO | adverse drug reactions monitoring in: WHO. World Health Organization 2015; [cited 3 Oct 2019]. Available: 2015

5. Kalaiselvan V.; Kumar P.; Mishra P.; Singh G.N.; System of adverse drug reactions reporting: What, where, how, and whom to report? Indian J Crit Care Med 2015,19(9),564-566

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3